A new path for patients with neurological disorders, leveraging soft implantable electrodes, just received a $3.0M grant. Neurosoft Bioelectronics, the company behind the technology, announced the funding to advance its unique approach to neural interfaces.
The company strives to improve patient care by developing extremely compliant neural interfaces that can achieve long-term bio-integration in the body. This unique technology is designed to improve therapeutic outcomes and open up new applications for neural interfaces that were previously impossible.


.png&w=3840&q=75)











